Address And Details
|P.O.Box 8528 , Boston, MA 02266|
|Fund Manager||William Eigen|
|Manager Tenure||13 Years 5 Months|
Strategy And Objective
The Fund seeks to provide high total return. The Fund has wide latitude to invest in all types of debt securities that the adviser believes have the potential to provide a high total return over time. As part of its principal investment strategy, the Fund may invest in corporate bonds, U.S. treasury obligations and other U.S. government and agency securities, asset-backed, mortgage-related and mortgage-backed securities and structured investments. Mortgage-related and mortgage-backed securities may be structured as adjustable rate mortgage loans, collateralized mortgage obligations (agency and non-agency), stripped mortgage-backed securities (interest-only or principal-only), commercial mortgage-backed securities, and mortgage pass-through securities including mortgage TBAs. These securities may be of any maturity.
Net Asset Value
- 1 Week
- 1 Month
- 3 Months
- 1 Yr Return
- 5 Yr Return
Equity Sector Breakdown
|Asset Type||% Of Allocation|
|Total Net Assets||87.47 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 10/31/2021||Average Annual Current Performance Quarterly As Of 09/30/2021||Avg Annual Current Performance Monthly As Of 10/31/2021||Avg Annual Current Performance Quarterly As Of 09/30/2021|
|Life Of Fund||
Master The Market with the Help of Our Financial Experts
Recent Articles from TheStreet
Facebook Owner Meta told by U.K. Antitrust Regulator to Sell Giphy
Facebook parent Meta has been order by the U.K.’s competition watchdog to sell GIF-sharing platform Giphy, which it bought in 2020 for a reported $400 million.
ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial
ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.
Lam Research and KLA: 2 Must-Own Chip-Equipment Stocks
Amid the chip shortage, two key equipment stocks fly under the radar: Lam Research and KLA.
Merck Covid-19 Pill to Be Reviewed by FDA Advisory Panel
Merck’s Covid-19 oral antiviral pill will be reviewed by an outside panel of advisors to the FDA on Tuesday, paving the way for potential authorization by year-end.
Moderna Stock Slumps, Regeneron Slides On Omicron Variant Efficacy Warnings
Moderna said its Covid vaccine would likely experience a 'material drop' in efficacy against Omicron, while Regeneron warned its antibody cocktail may also have reduced activity against the new variant.
Moderna Warns on Omicron, Powell, Yellen Face Senate - 5 Things You Must Know
Stocks slump as Omicron concerns resurface; Moderna CEO cautions on vaccine efficacy against new variant; Powell and Yellen to testify before the Senate Banking Committee on CARES Act; FTC orders supply chain probe and cloud adoption software group HashiCorp seeks $13 billion valuation in upcoming Nasdaq IPO.
Cramer's Mad Money Recap 11/29: Omicron, Amazon, Netflix
Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.